These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 529620)

  • 1. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dialysis bone disease in children. Six cases (author's transl)].
    Luciani JC; Ferran JL; Dumas ML; Meunier P; Dumas R
    Nouv Presse Med; 1977 Nov; 6(39):3616-9. PubMed ID: 607175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G; Schaefer K; Schulz A; Delling G
    Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha-hydroxychloecalciferol treatment of long-term hemodialyzed patients. Effects on mineral metabolism, bone mineral content and bone morphometry.
    Nielsen HE; Melsen F; Christensen MS; Hansen HE; Rodbro P; Johannsen A
    Clin Nephrol; 1977 Oct; 8(4):429-34. PubMed ID: 923161
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on calcium-regulating hormone in patients on chronic hemodialysis with special reference to renal osteodystrophy (ROD) (author's transl)].
    Kudo S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):181-96. PubMed ID: 7098141
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of photon absorptiometry in renal osteodystrophy (author's transl)].
    Samizadeh A; Loew H; Busch G; Müller H; Losse H
    Klin Wochenschr; 1977 Oct; 55(20):1005-1011. PubMed ID: 200791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.
    Muirhead N; Adami S; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Proc Eur Dial Transplant Assoc; 1981; 18():567-72. PubMed ID: 6895786
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 15. COSMOS Project: Hemodialysis scenario in Europe.
    Cannata-Andía JB; Fernández Martín JL
    Nefrologia; 2016; 36(4):381-8. PubMed ID: 27117398
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium metabolism and kidney disease.
    Binswanger U
    Ergeb Inn Med Kinderheilkd; 1974; 34(0):105-53. PubMed ID: 4608434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum iPTH concentration in chronic renal failure and its relationship to calcium metabolism (author's transl)].
    Asano Y; Kusano E; Marumo F; Torigai S; Kikawada R; Matsubayashi T; Sato S; Hirata S
    Nihon Jinzo Gakkai Shi; 1978 Jul; 20(7):747-57. PubMed ID: 722977
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)].
    Sebert JL; Fournier A; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(37):3419-24. PubMed ID: 341075
    [No Abstract]   [Full Text] [Related]  

  • 19. How important is phosphate in the pathogenesis of renal osteodystrophy?
    Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
    Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum and renal osteodystrophy in chronic uremia.
    Berland Y; Grandvuillemin M; Charhon S; Olmer M
    Kidney Int Suppl; 1985 Dec; 17():S183-7. PubMed ID: 3867793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.